[Evaluation of clinical characteristics, MYD88(L265P) mutation, CXCR4(WHIM) mutation and prognosis in Waldenström macroglobulinemia: A single center retrospective study of 93 patients].

Cao, X X; Meng, Q; Cai, H; Mao, Y Y; Duan, M H; Zhu, T N; Zhang, W; Han, B; Zhuang, J L; Cai, H C; Chen, M; Feng, J; Han, X; Zhang, Y; Yang, C; Zhang, L; Zhou, D B; Li, J

Cao, X X; Meng, Q; Cai, H; Mao, Y Y; Duan, M H; Zhu, T N; Zhang, W; Han, B; Zhuang, J L; Cai, H C; Chen, M; Feng, J; Han, X; Zhang, Y; Yang, C; Zhang, L; Zhou, D B; Li, J.

Affiliation

Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

Zhonghua Xue Ye Xue Za Zhi ; 38(6): 494-498, 2017 Jun 14.

Article in Zh | MEDLINE | ID: mdl-28655092

Subject(s)
Key words

Mutation; Myeloid Differentiation Factor 88; Receptors, CXCR4; Waldenström macroglobulinemia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Waldenstrom Macroglobulinemia Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2017 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google